UNIVERSITY OF VIRGINIA HEALTH SYSTEM “THIS TRIAL ESTABLISHED THAT BALOXAVIR, IF TAKEN WITHIN A DAY OR SO AFTER EXPOSURE, IS HIGHLY EFFECTIVE FOR PREVENTING INFLUENZA ILLNESS IN HOUSEHOLDS, A HIGH-RISK SETTING FOR VIRUS TRANSMISSION, ” SAID… view more CREDIT: DAN ADDISON | UVA COMMUNICATIONS A single dose of the flu drug baloxavir marboxil can reduce...
DALLAS, July 13, 2020 — Women taking beta blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospital with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal. Beta blockers are...
Researchers at the Medical University of South Carolina have formulated a vitamin K-based compound that, due to its unique structure and mechanism, eliminates medication-resistant epileptic seizures in mice tested to date. Credit: Sarah Pack, Medical University of South Carolina In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a...
Checkpoint blockade by a D-peptide for cancer immunotherapy or example, they induce the so-called immune checkpoints of T-cells to shut down immune responses. In the journal Angewandte Chemie, scientists have now introduced a new approach for immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable “mirror-image”...
Hypertension Journal Report AMERICAN HEART ASSOCIATION DALLAS, July 6, 2020 — Medications commonly prescribed to treat high blood pressure may also reduce patients’ colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal. Angiotensin converting enzyme inhibitor (ACE-i) or angiotensin II receptor blocker (ARB) medications are prescribed for conditions...
Children with COVID-19 may present with new neurological symptoms involving the central and peripheral nervous systems, and splenial changes on imaging, according to a study published online July 1 in JAMA Neurology. Omar Abdel-Mannan, M.D., from Great Ormond Street Hospital for Children in London, and colleagues reported neurological manifestations of children with COVID-19 in a...
by Max Planck Society Erythropoietin (Epo) is actually a medication for anemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against COVID-19. The growth factor could mitigate severe disease progression and protect patients from long-term neurological effects when the SARS-CoV-2 virus attacks...
University of Alberta-led team develops synthetic molecule that stops production of toxic muscle-killing protein UNIVERSITY OF ALBERTA FACULTY OF MEDICINE & DENTISTRY UNIVERSITY OF ALBERTA MEDICAL GENETICIST TOSHIFUMA YOKOTA LED A RESEARCH TEAM THAT CREATED A POTENTIAL NEW TREATMENT FOR ONE OF THE MOST COMMON FORMS OF MUSCULAR DYSTROPHY. Researchers have designed a potential new...
A NOVEL FORMULATION OF THE PROSTATE CANCER DRUG ABIRATERONE ACETATE – CURRENTLY MARKETED AS ZYTIGA – WILL DRAMATICALLY IMPROVE THE QUALITY OF LIFE FOR PEOPLE SUFFERING FROM PROSTATE CANCER.view more CREDIT: HAYLEY SCHULTZ/UNISA A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of...
This article by Dr. Vivekanandan Palaninathan et al. is published in Current Pharmaceutical Design, 2020 BENTHAM SCIENCE PUBLISHERS Direct reprogramming or Transdifferentiation is a way of inducing changes in the cell type from one lineage into another lineage, bypassing pluripotency. This approach is an innovative choice to replace the lost cardiomyocytes after an end-stage myocardial...
